UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
European journal of medicinal chemistry, ISSN 0223-5234, 02/2021, Volume 211, pp. 113083 - 113083
Journal Article
Cancer research (Chicago, Ill.), ISSN 0008-5472, 05/2005, Volume 65, Issue 10, pp. 4389 - 4400
Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Medical sciences | Antineoplastic agents | Pharmacology. Drug treatments | Tumors | Corpus Luteum - drug effects | Corpus Luteum - growth & development | Humans | Quinazolines - pharmacokinetics | Biological Availability | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Vascular Endothelial Growth Factor Receptor-2 - antagonists & inhibitors | Extracellular Matrix Proteins | Female | Phosphorylation - drug effects | Protein Kinase Inhibitors - pharmacokinetics | Bone Development - drug effects | Administration, Oral | Endothelial Cells - metabolism | Neoplasms - enzymology | Vascular Endothelial Growth Factor Receptor-2 - metabolism | Neoplasms - blood supply | Neoplasms - drug therapy | Xenograft Model Antitumor Assays | Animals | Myosin Heavy Chains | Nonmuscle Myosin Type IIB | Cell Proliferation - drug effects | Mice | Protein Kinase Inhibitors - pharmacology | Neoplasms - pathology | Quinazolines - pharmacology | Endothelial Cells - enzymology | Proteins - antagonists & inhibitors | Vascular Endothelial Growth Factor Receptor-3 - antagonists & inhibitors | Endothelial Cells - drug effects | Index Medicus
Journal Article
Circulation research, ISSN 0009-7330, 02/2006, Volume 98, Issue 2, pp. 209 - 217
Bone morphogenetic proteins | Bone morphogenetic receptor-2 | Pulmonary arterial hypertension | Endothelial cells | Endothelial progenitor cells | Apoptosis | Cardiac & Cardiovascular Systems | Peripheral Vascular Disease | Life Sciences & Biomedicine | Hematology | Cardiovascular System & Cardiology | Science & Technology | Fundamental and applied biological sciences. Psychology | Biological and medical sciences | Pulmonary hypertension. Acute cor pulmonale. Pulmonary embolism. Pulmonary vascular diseases | Medical sciences | Vertebrates: cardiovascular system | Pneumology | Bone Morphogenetic Protein Receptors, Type II - genetics | Bone Morphogenetic Protein 2 | Cell Survival | Humans | Middle Aged | Cells, Cultured | Male | Transforming Growth Factor beta - pharmacology | Stem Cells - drug effects | Adult | Female | Signal Transduction - physiology | Aged | Bone Morphogenetic Protein Receptors, Type II - analysis | Bone Morphogenetic Protein Receptors, Type II - physiology | Mutation | Endothelial Cells - pathology | Bone Morphogenetic Proteins - pharmacology | Hypertension, Pulmonary - etiology | Hypertension, Pulmonary - pathology | Pulmonary Artery - pathology | Endothelial Cells - drug effects | Index Medicus
Journal Article
Cancer science, ISSN 1347-9032, 04/2018, Volume 109, Issue 4, pp. 1207 - 1219
VEGFR2 | tyrosine kinase inhibitor | anlotinib | angiogenesis | VEGF | Life Sciences & Biomedicine | Oncology | Science & Technology | Human Umbilical Vein Endothelial Cells | Humans | Male | Vascular Endothelial Growth Factor A - metabolism | Quinolines - pharmacology | Vascular Endothelial Growth Factor Receptor-2 - antagonists & inhibitors | Sunitinib | Female | Indoles - pharmacology | Antineoplastic Agents - pharmacology | Cell Line | Angiogenesis Inhibitors - pharmacology | Rats | Rats, Sprague-Dawley | Pyrroles - pharmacology | Animals | Signal Transduction - drug effects | Mice, Nude | Neovascularization, Pathologic - drug therapy | Cell Line, Tumor | Cell Proliferation - drug effects | Mice | Neovascularization, Pathologic - metabolism | Protein Kinase Inhibitors - pharmacology | Protein-Tyrosine Kinases - antagonists & inhibitors | Tyrosine | Vascular endothelial growth factor | Analysis | Cell proliferation | Lung cancer | Metastasis | Kinases | Drug resistance | Cancer therapies | Cell adhesion & migration | Angiogenesis | Hydrogen bonds | Aorta | Drug dosages | Protein-tyrosine kinase | Explants | Immunoglobulins | Regression analysis | Studies | Chemotherapy | Antitumor activity | Hypoxia | Mutation | Angiogenesis inhibitors | Cell migration | Pharmaceuticals | Tumors | Index Medicus | Original
Journal Article
Molecular imaging and biology, ISSN 1536-1632, 2/2018, Volume 20, Issue 1, pp. 85 - 93
Molecular imaging | Vascular endothelial growth factor receptor (VEGFR) | Diabetes | Medicine & Public Health | Imaging / Radiology | Atherosclerosis | Life Sciences & Biomedicine | Radiology, Nuclear Medicine & Medical Imaging | Science & Technology | Atherosclerosis - pathology | Diabetes Mellitus, Experimental - diagnosis | Apolipoproteins E - deficiency | Tomography, Emission-Computed, Single-Photon | Vascular Endothelial Growth Factor Receptor-2 - metabolism | Atherosclerosis - complications | Male | Molecular Imaging - methods | Polyethylene Glycols - chemistry | Vascular Endothelial Growth Factor Receptor-1 - metabolism | Apolipoproteins E - metabolism | Atherosclerosis - metabolism | Diabetes Mellitus, Experimental - blood | Tissue Distribution | Animals | Atherosclerosis - diagnosis | Diabetes Mellitus, Experimental - complications | Mice | Single-Chain Antibodies | Blood Glucose - metabolism | Diabetes Mellitus, Experimental - metabolism | Selectivity | Biology | Proteins | Angiogenesis | Receptors | Computed tomography | Apolipoprotein E | Polyethylene glycol | Imaging | Tomography | Aorta | Lesions | Vascular endothelial growth factor | Plaques | Photon emission | Medical imaging | Diabetes mellitus | Blood vessels | Single photon emission computed tomography | Mutants | Vascular endothelial growth factor receptors | Signaling | Computation | Arteriosclerosis | Coronary vessels | Tracers | Index Medicus
Journal Article
Annals of oncology, ISSN 0923-7534, 06/2015, Volume 26, Issue 6, pp. 1230 - 1237
phase I study | ramucirumab | VEGFR-2 | vascular endothelial growth factor | solid tumors | Phase I study | Ramucirumab | Solid tumors | Vascular endothelial growth factor | Life Sciences & Biomedicine | Oncology | Science & Technology | United States | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Male | Vascular Endothelial Growth Factor Receptor-2 - immunology | Angiogenesis Inhibitors - blood | Antibodies, Monoclonal - blood | Antibodies, Monoclonal, Humanized | Vascular Endothelial Growth Factor Receptor-2 - antagonists & inhibitors | Angiogenesis Inhibitors - administration & dosage | Neoplasms - blood | Adult | Female | Angiogenesis Inhibitors - adverse effects | Drug Administration Schedule | Vascular Endothelial Growth Factor A - blood | Antibodies, Monoclonal - pharmacokinetics | Neoplasms - enzymology | Vascular Endothelial Growth Factor Receptor-2 - blood | Treatment Outcome | Angiogenesis Inhibitors - pharmacokinetics | Disease Progression | Neoplasms - drug therapy | Biomarkers, Tumor - blood | Maximum Tolerated Dose | Antibodies, Monoclonal - administration & dosage | Neoplasms - immunology | Aged | Neoplasms - pathology | Vascular Endothelial Growth Factor Receptor-1 - blood | Index Medicus
Journal Article
Angewandte Chemie (International ed.), ISSN 1433-7851, 10/2016, Volume 55, Issue 43, pp. 13524 - 13528
ruthenium | VEGFRs | anti-cancer | angiogenesis | Physical Sciences | Chemistry | Chemistry, Multidisciplinary | Science & Technology | Ruthenium | Endothelial growth factors | Analysis | Cancer | Angiogenesis | Vascular endothelial growth factor | Rodents | Biotechnology | Cytotoxicity | Zebrafish | Tumor cell lines | Vascular endothelial growth factor receptors | Down-regulation | Xenografts | Inhibition | Index Medicus
Journal Article
The Journal of pathology, ISSN 0022-3417, 11/2018, Volume 246, Issue 3, pp. 311 - 322
neuropilin 1 | pancreatic adenocarcinoma | trans‐complex | branching | VEGF | trans-complex | Pathology | Oncology | Life Sciences & Biomedicine | Science & Technology | Antigen-antibody reactions | Endothelial growth factors | Sarcoma | RNA | Biological control | Antibodies | Development and progression | Pests | Endothelium | Viral antibodies | Pancreatic cancer | Analysis | Cellular signal transduction | Cell proliferation | Adenocarcinoma | Complex formation | Cell survival | Tumor cells | Neuropilin | Fibrosarcoma | Survival | Endothelial cells | Signal transduction | Angiogenesis | Cell growth | Vascular endothelial growth factor | Growth factors | Cancer | Tumors | Index Medicus | Original Papers | Original Paper
Journal Article
British journal of dermatology (1951), ISSN 0007-0963, 01/2014, Volume 170, Issue 1, pp. 78 - 86
Life Sciences & Biomedicine | Dermatology | Science & Technology | Public health. Hygiene-occupational medicine | Public health. Hygiene | Biological and medical sciences | Medical sciences | Prevention and actions | Human Umbilical Vein Endothelial Cells | Humans | Angiogenesis Inhibitors - pharmacology | Hemangioma - physiopathology | Adrenergic beta-Antagonists - pharmacology | Phthalazines - pharmacology | Proto-Oncogene Proteins c-bcl-2 - metabolism | Propranolol - pharmacology | Up-Regulation - physiology | Pyridines - pharmacology | Vascular Endothelial Growth Factor Receptor-2 - physiology | Apoptosis - physiology | Culture Media, Serum-Free - pharmacology | Propanolamines - pharmacology | Proto-Oncogene Proteins c-akt - metabolism | Vascular Endothelial Growth Factor A - physiology | Cell Survival - physiology | Endothelial Cells - physiology | Propranolol hydrochloride | Hemangioma | Starvation | Vascular endothelial growth factor | Analysis | Apoptosis | Index Medicus
Journal Article